Advertisement

Massachusetts startup SynapDx announced on Wednesday that it will work with DNA sequencer manufacturer Illumina  to develop early detection tools for autism spectrum disorders, according to a release.

SynapDx is trying to develop a blood-based test that will catch most cases of autism spectrum disorders in children earlier than current methods (see “Can a Blood Test Detect Autism Early?”). The advantage would be that treatments seem to work better the sooner they start. The challenge is that there aren’t clear biomarkers or genetic signals for the disorder, which is most likely a mix of many different conditions.

Advertisement
Advertisement